Edwards Lifesciences Corporation E1WL34.SA Stock
Edwards Lifesciences Corporation Price Chart
Edwards Lifesciences Corporation E1WL34.SA Financial and Trading Overview
Edwards Lifesciences Corporation stock price | 115.32 BRL |
Previous Close | 110.38 BRL |
Open | 0 BRL |
Bid | 108.46 BRL x N/A |
Ask | 111.43 BRL x N/A |
Day's Range | 0 - 0 BRL |
52 Week Range | 0 - 140.5 BRL |
Volume | 0 BRL |
Avg. Volume | 87 BRL |
Market Cap | 264.76B BRL |
Beta (5Y Monthly) | 1.01338 |
PE Ratio (TTM) | 8.56651 |
EPS (TTM) | 11.72 BRL |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
E1WL34.SA Valuation Measures
Enterprise Value | 267.18B BRL |
Trailing P/E | 8.56651 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 48.131954 |
Price/Book (mrq) | 44.391285 |
Enterprise Value/Revenue | 48.57 |
Enterprise Value/EBITDA | 139.038 |
Trading Information
Edwards Lifesciences Corporation Stock Price History
Beta (5Y Monthly) | 1.01338 |
52-Week Change | -3.047% |
S&P500 52-Week Change | 20.43% |
52 Week High | 140.5 BRL |
52 Week Low | 0 BRL |
50-Day Moving Average | 106.81 BRL |
200-Day Moving Average | 104.67 BRL |
E1WL34.SA Share Statistics
Avg. Volume (3 month) | 87 BRL |
Avg. Daily Volume (10-Days) | 128 BRL |
Shares Outstanding | 606.22M |
Float | 2.4B |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 0.0010% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 3:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 27.06% |
Operating Margin (ttm) | 32.38% |
Gross Margin | 79.83% |
EBITDA Margin | 34.93% |
Management Effectiveness
Return on Assets (ttm) | 13.04% |
Return on Equity (ttm) | 25.00% |
Income Statement
Revenue (ttm) | 5.5B BRL |
Revenue Per Share (ttm) | 2.23 BRL |
Quarterly Revenue Growth (yoy) | 8.79% |
Gross Profit (ttm) | 4.3B BRL |
EBITDA | 1.92B BRL |
Net Income Avi to Common (ttm) | 1.49B BRL |
Diluted EPS (ttm) | 12.78 |
Quarterly Earnings Growth (yoy) | -8.90% |
Balance Sheet
Total Cash (mrq) | 1.25B BRL |
Total Cash Per Share (mrq) | 0.52 BRL |
Total Debt (mrq) | 687.8M BRL |
Total Debt/Equity (mrq) | 11.35 BRL |
Current Ratio (mrq) | 3.01 |
Book Value Per Share (mrq) | 2.46625 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.24B BRL |
Levered Free Cash Flow (ttm) | 994.54M BRL |
Profile of Edwards Lifesciences Corporation
Country | Brazil |
State | CA |
City | Irvine |
Address | One Edwards Way |
ZIP | 92614 |
Phone | 949 250 2500 |
Website | https://www.edwards.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 17300 |
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Q&A For Edwards Lifesciences Corporation Stock
What is a current E1WL34.SA stock price?
Edwards Lifesciences Corporation E1WL34.SA stock price today per share is 115.32 BRL.
How to purchase Edwards Lifesciences Corporation stock?
You can buy E1WL34.SA shares on the São Paulo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Edwards Lifesciences Corporation?
The stock symbol or ticker of Edwards Lifesciences Corporation is E1WL34.SA.
Which industry does the Edwards Lifesciences Corporation company belong to?
The Edwards Lifesciences Corporation industry is Medical Devices.
How many shares does Edwards Lifesciences Corporation have in circulation?
The max supply of Edwards Lifesciences Corporation shares is 2.4B.
What is Edwards Lifesciences Corporation Price to Earnings Ratio (PE Ratio)?
Edwards Lifesciences Corporation PE Ratio is 9.83959000 now.
What was Edwards Lifesciences Corporation earnings per share over the trailing 12 months (TTM)?
Edwards Lifesciences Corporation EPS is 11.72 BRL over the trailing 12 months.
Which sector does the Edwards Lifesciences Corporation company belong to?
The Edwards Lifesciences Corporation sector is Healthcare.